Retroviral gene transfer into primary human natural killer cells
- PMID: 19110624
- DOI: 10.1007/978-1-59745-409-4_10
Retroviral gene transfer into primary human natural killer cells
Abstract
Modulation of intracellular signaling pathways or receptor expression in natural killer (NK) cells by genetic manipulation is an attractive possibility in studies of NK cell specificity and function. Moreover, feasible applications of these genetic manipulations in the context of gene and NK cell therapy regimens may be considered. However, efficient gene modification of primary NK cells has been largely hampered by the absence of an efficient gene-transfer protocol.A retrovirus-based easy-to-use transduction protocol that can insert the gene of interest permanently into primary NK cells would be an important tool to advance our studies in NK cell biology and NK cell-mediated therapies. We have recently described a protocol for efficient expansion of NK cells under good manufacturing practice (GMP) conditions from the healthy donors and from patients with hematological malignancies. As the active division of cells is a prerequisite for efficient retroviral insertion, the high rate of expansion in this protocol provides more efficient transduction by retroviral vectors. We hereby present this simple and efficient retroviral vector-based gene-transfer protocol for such ex vivo cultured primary human NK cells.
Similar articles
-
Efficient gene transfer into primary human natural killer cells by retroviral transduction.Exp Hematol. 2005 Nov;33(11):1320-8. doi: 10.1016/j.exphem.2005.07.006. Exp Hematol. 2005. PMID: 16263416
-
Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector.J Immunol Methods. 2005 Jan;296(1-2):115-23. doi: 10.1016/j.jim.2004.11.012. Epub 2004 Dec 8. J Immunol Methods. 2005. PMID: 15680156
-
High-efficient lentiviral vector-mediated gene transfer into primary human NK cells.Exp Hematol. 2006 Oct;34(10):1344-52. doi: 10.1016/j.exphem.2006.06.001. Exp Hematol. 2006. PMID: 16982327
-
Retroviral cell targeting vectors.Curr Opin Mol Ther. 1999 Oct;1(5):613-21. Curr Opin Mol Ther. 1999. PMID: 11249668 Review.
-
Retroviral bicistronic vectors.Drug News Perspect. 2008 Nov;21(9):473-80. doi: 10.1358/dnp.2008.21.9.1290817. Drug News Perspect. 2008. PMID: 19180265 Review.
Cited by
-
INTASYL self-delivering RNAi decreases TIGIT expression, enhancing NK cell cytotoxicity: a potential application to increase the efficacy of NK adoptive cell therapy against cancer.Cancer Immunol Immunother. 2024 Oct 3;73(12):239. doi: 10.1007/s00262-024-03835-x. Cancer Immunol Immunother. 2024. PMID: 39358647 Free PMC article.
-
Engineered NK Cells Against Cancer and Their Potential Applications Beyond.Front Immunol. 2022 Feb 15;13:825979. doi: 10.3389/fimmu.2022.825979. eCollection 2022. Front Immunol. 2022. PMID: 35242135 Free PMC article. Review.
-
Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies.J Immunol Res. 2018 Sep 17;2018:4054815. doi: 10.1155/2018/4054815. eCollection 2018. J Immunol Res. 2018. PMID: 30306093 Free PMC article. Review.
-
Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins.J Vis Exp. 2018 Jun 14;(136):58237. doi: 10.3791/58237. J Vis Exp. 2018. PMID: 29985369 Free PMC article.
-
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.Front Immunol. 2015 Nov 30;6:605. doi: 10.3389/fimmu.2015.00605. eCollection 2015. Front Immunol. 2015. PMID: 26648934 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials